Vital Chemtech Limited IPO Message Board (Page 13)

Will be a very good IPO unless hugely priced. Will be difficult to get due to high subscription and QIB factor. Only 6400000 L shares.

No need of unnecessary spat amongst members. Pricing and subscription will say it all. Listing gains are very likely.

IMO, High growth in revenue and PAT neutralizes the negative of high debt to equity ratio, which company may reduce also in future from profits generated.

Business of Company Good. Sale and profits are also Grow. Promoters have experience of industry from years. Only negetive thing is Debts. Very High. Debt equity ratio not favourite. If Company utilise IPO proceeds to repay loans then a good part. But big no. If there should less debts then I blind apply this IPO at any Issue price. But now wait for offer price. To see the SME fomo and absence of any mainline IPO the issue subscribe equal to FHANTOM. The company far better than FHANTOM.I think grey start from mnm 50000 SBTA.

@Admin

Pre Issue Capital 175515000
Pre Issue Shares 17551500

LM is beeline.

Debt to Equity ratio at 2.31 (as on April 30, 2022)
Debt - 35.5 crores.

Very high debt and they don't have any plan to repay debt also out of IPO proceeds, as per object of IPO.

@IPO Share sir / ma’am

The Debt is just around 8 cr .. rest is by promoter and promoter group.
You can check with the co itself if you like.
Good fundamental business of Chemcials as per my investigation and my research only.
All opinions are welcome

₹1 dividend diya
₹15 down ho gaya 😊

Got 1 rs dividend in le merite.

I already sold my loat at 75 rs last weak.

All debt ridden company are doing bad after listing
veekayem,safa (holding 1 lot),lemerite etc.

At present
Pros:
1. Good business
2. Assets, revenue, PAT: ok
3. Sustained for 10 years

Cons:
1. QIB: less lots to nii and rii
2. Failed to reduce BORROWING.

Final conclusion after declaration of price band, but will double in one year from listing price.

Question ❓ about total borrowings